Q3 2024 13F Holders as of 30 Sep 2024
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
120,284,725
-
Number of holders
-
61
-
Total 13F shares, excl. options
-
55,990,706
-
Shares change
-
+2,269,500
-
Total reported value, excl. options
-
$92,402,857
-
Value change
-
+$4,082,986
-
Put/Call ratio
-
306591%
-
Number of buys
-
28
-
Number of sells
-
-19
-
Price
-
$1.65
Significant Holders of IMMUNIC, INC. - Common Stock (IMUX) as of Q3 2024
71 filings reported holding IMUX - IMMUNIC, INC. - Common Stock as of Q3 2024.
IMMUNIC, INC. - Common Stock (IMUX) has 61 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 55,990,706 shares
of 120,284,725 outstanding shares and own 47% of the company stock.
Largest 10 shareholders include BVF INC/IL (8,902,972 shares), Avidity Partners Management LP (8,266,000 shares), Soleus Capital Management, L.P. (7,293,007 shares), ADAGE CAPITAL PARTNERS GP, L.L.C. (5,594,406 shares), JANUS HENDERSON GROUP PLC (5,099,278 shares), VANGUARD GROUP INC (4,700,016 shares), RTW INVESTMENTS, LP (4,567,717 shares), Colony Group, LLC (2,144,743 shares), Omega Fund Management, LLC (1,788,160 shares), and GEODE CAPITAL MANAGEMENT, LLC (945,533 shares).
This table shows the top 61 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.